News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Dispatches from BioPharma Expo, Japan
Lonza will install four 2,000L single-use bioreactors at its Singapore facility to cater for growing demand for small to mid-volume biologics production.
Coherus Biosciences has submitted a US Securities and Exchange Commission filing, announcing it will eliminate 51 jobs to reduce operating costs.
Patheon NV has announced it will spend $45m to expand and enhance its manufacturing network citing customer demand for more reliable, flexible and cost-efficient supply chains.